Factors associated with participation in research conducted in a pediatric emergency department

Regina G Taylor1, Melanie Hounchell, Mona Ho

  • 1From the Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Insights

Study characteristics and demographics influence participation in pediatric emergency department (PED) clinical research. Younger children and White patients were more likely to participate, while invasiveness and time commitment affected enrollment in more intensive studies.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Research Participation

Background:

  • Understanding factors influencing participation in pediatric emergency department (PED) clinical research is crucial for successful study design and recruitment.
  • Previous research has not fully elucidated the interplay between demographic variables and study characteristics on enrollment in PED settings.

Purpose of the Study:

  • To investigate the association between demographic factors and study characteristics with participation in clinical research conducted within a pediatric emergency department.
  • To identify predictors of participation versus non-participation in PED-based research studies.

Main Methods:

  • A 6-year electronic database analysis of families approached for PED clinical research.
  • Inclusion of 40 studies, examining demographic factors, participation decisions, reasons for non-participation, and study characteristics.
  • Multivariable logistic regression to determine the likelihood of participation based on various factors.

Main Results:

  • Participation rates were similar across sexes but higher for families with younger children (mean age 8.5 vs 10.2 years).
  • White patients (54.7%) were more likely to participate than African American patients (45.6%).
  • Compensation, brief time, and older children negatively impacted participation in invasive studies, but not in noninvasive ones.

Conclusions:

  • Demographic factors (age, race) and study characteristics (invasiveness, time, compensation) significantly influence participation in PED clinical research.
  • Future PED research designs should consider these factors and explore novel strategies to enhance inclusivity across all racial and ethnic groups.
Abstract

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.3K
Group Design02:01

Group Design

The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
11.1K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
210
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391